AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05946434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio Tape Group
Description: Physiotherapy Protocol Followed:~* Hot pack and TENS application for 10 minutes.~* Knee isometric exercises by placing roller beneath knee joint and pressing it by keeping leg straight and holding it for 10-15 seconds with 10 repetitions.~* Stretching of hamstrings and gastrocnemius muscles, maintaining stretch for 20 seconds and 7 repetitions should be performed.~* Tibio-femoral glides and patellar mobilizations will be performed.~* At the end kinesio taping will be performed at knee joint for inhibition.~Same procedure will be followed in all follow ups at day 1, day 14 and day 28.
Study NCT05946434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rigid Tape Group
Description: Physiotherapy Protocol Followed:~* Hot pack and TENS application for 10 minutes.~* Knee isometric exercises by placing roller beneath knee joint and pressing it by keeping leg straight and holding it for 10-15 seconds with 10 repetitions.~* Stretching of hamstrings and gastrocnemius muscles, maintaining stretch for 20 seconds and 7 repetitions should be performed.~* Tibio-femoral glides and patellar mobilizations will be performed.~* At the end rigid tape will be applied on knee joint to provide stability.~Same procedure will be followed in all follow ups at day 1, day 14 and day 28
Study NCT04953676 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: round tunnel technique
Description: Both the femoral tunnel and tibial tunnel were drilled by 8-mm cannulated drill
Study NCT04953676 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: flat tunnel technique
Description: Both the femoral tunnel and tibial tunnel were dimension of 5×11-mm rounded-rectangular, which was created by initially drilling a round tunnel with a 5-mm cannulated drill and reshaped by use of a bone rasp and custom-made dilator.
Study NCT06337721 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction)
Description: This behavioral group intervention will consist of multiple group sessions to reduce AUDs and alcohol-related harms in Pacific Islander young adults. It will infuse culturally resonant narratives, language, and elements into existing evidence-based strategies.
Study NCT06225076 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Comprehensive rehabilitation
Description: All the participants are provided with the comprehensive rehabilitation (routine rehabilitation and swallowing function training). The routine rehabilitation included intervention for risk factors (blood pressure, blood lipids, blood glucose, smoking and alcohol restriction, exercise, etc.).~Regrading swallowing function training, both groups are given swallowing function training, including 1) exercises of closure of the vocal folds, pharyngeal, and laryngeal muscles exercises, and respiratory muscle strength training, for 15 min each time and twice per day. 2) isotonic／isometric swallowing exercises, supraglottic swallowing exercises, for 20 min each time and twice per day. 3) effortful swallowing exercises, and cough reflex training, for 10 min each time and twice per day.
Study NCT06225076 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation
Description: All the participants are provided with the comprehensive rehabilitation (routine rehabilitation and swallowing function training). The routine rehabilitation included intervention for risk factors (blood pressure, blood lipids, blood glucose, smoking and alcohol restriction, exercise, etc.).~Regrading swallowing function training, both groups are given swallowing function training, including 1) exercises of closure of the vocal folds, pharyngeal, and laryngeal muscles exercises, and respiratory muscle strength training, for 15 min each time and twice per day. 2) isotonic／isometric swallowing exercises, supraglottic swallowing exercises, for 20 min each time and twice per day. 3) effortful swallowing exercises, and cough reflex training, for 10 min each time and twice per day.
Study NCT06225076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block
Description: the patients in the observation group were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06225076 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: the patients in the observation group were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06248827 — intervention group
Intervention type: OTHER
Intervention: Data Collection
Description: Patient data : gender, age, height, weight, daily life (type of job) Diagnostic data : Description of first symptoms/medical history (pain), previous medical history, MRI exams
Study NCT06278545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: modified FOLFORINOX
Description: One treatment every 14 days :~* Irinotecan 180mg/m² as a 2-hour IV infusion~* Oxaliplatin 85 mg/m² as a 2-hour IV infusion~* Folinic acid 400 mg/m² as 2-hour IV infusion, in Y with oxaliplatin~* 5-FU 2400 mg/m² as a continuous IV infusion over 46 hours
Study NCT06278545 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modified FOLFOX
Description: One treatment every 14 days:~* Oxaliplatin 85 mg/m by IV infusion over 2 hours~* Folinic acid: 400 mg/m² or 200 mg/m² if laevorotatory form by IV infusion over 2 hours, in Y with oxaliplatin~* 5FU bolus: 400 mg/m² per 10-minute IV infusion~* 5 FU continuous 2400 mg/m² by IV infusion over 46 hours
Study NCT06118970 — intervention group
Intervention type: OTHER
Intervention: Neuropsychological tasks and self-report questionnaires
Description: Being a cross-sectional observational study, no intervention will be administered. Subjects will be assessed with neuropsychological tasks and self-report questionnaires.
Study NCT05700565 — intervention group
Intervention type: OTHER
Intervention: Extracorporeal photopheresis
Description: ECP consists of the three steps of leukapheresis, photoactivation and reinfusion and has immunomodulatory effects (modulation of dendritic cells, change in cytokine profile, induction of T cell subpopulations). Indications are currently the treatment of Sézary syndrome, Graft-versus-host disease (GvHD), organ transplant rejection and systemic scleroderma.
Study NCT05700565 — intervention group
Intervention type: OTHER
Intervention: Other immunosuppressive or immunomodulatory drugs
Description: Other immunosuppressive or immunomodulatory drugs
Study NCT06139042 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood drawing
Description: The participants had their blood drawn.
Study NCT06146894 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single obturation technique (Bioceramic Sealer)
Description: Root canal will be obturated using single cone technique using Bioceramic Sealer
Study NCT06146894 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lateral condensation technique (Bioceramic Sealer)
Description: Root canal will be obturated using lateral condensation technique using Bioceramic Sealer
Study NCT06146894 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Warm Vertical condensation technique (Bioceramic Sealer)
Description: Root canal will be obturated using vertical condensation technique using Bioceramic Sealer
Study NCT06146894 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lateral condensation technique (AH Plus Sealer)
Description: Root canal will be obturated using lateral condensation technique using AH plus Sealer
Study NCT06146894 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Warm Vertical condensation technique (AH plus Sealer)
Description: Root canal will be obturated using vertical condensation technique using AH plus Sealer
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measure the improvement in quality of life
Description: Improvment of quality of life is measured by the QLQ-C30 quality of life questionnaire
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Measure the improvement in quality of life
Description: Improvment of quality of life is measured by the QLQ-C30 quality of life questionnaire
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measure the level of satisfaction of patients and nursing staff
Description: Patient satisfaction is measured using a five-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Higher scores indicate higher levels of satisfaction.
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Measure the level of satisfaction of patients and nursing staff
Description: Patient satisfaction is measured using a five-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Higher scores indicate higher levels of satisfaction.
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement of anxiety and pain
Description: Anxiety and pain is measured by Visual Analogue Scale (VAS). This measurement is complemented by physiological responses to anxiety, measured by heart rate and mean arterial blood pressure (HR and BP)
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of anxiety and pain
Description: Anxiety and pain is measured by Visual Analogue Scale (VAS). This measurement is complemented by physiological responses to anxiety, measured by heart rate and mean arterial blood pressure (HR and BP)
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement of depressive state
Description: Depressive State is measured by HAD score
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of depressive state
Description: Depressive State is measured by HAD score
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: measuring fatigue levels
Description: Fatigue levels is measured by Visual Analogue Scale (VAS).
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: measuring fatigue levels
Description: Fatigue levels is measured by Visual Analogue Scale (VAS).
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: measurement of acute nausea and vomiting
Description: acute nausea and vomiting is measured by MASCC Antiemesis Tool (MAT)
Study NCT06485869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: measurement of acute nausea and vomiting
Description: acute nausea and vomiting is measured by MASCC Antiemesis Tool (MAT)
Study NCT04616066 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dates
Description: The effect of date phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes
Study NCT04616066 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Raisins
Description: The effect of raisins phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes
Study NCT05722964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1906
Description: Intravenous injection
Study NCT05722964 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo，Intravenous injection
Study NCT05884762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electroencephalographic neurofeedback
Description: The patient is installed in a quiet, isolated room in the Physical Medicine and Rehabilitation Department. The patient sits comfortably in front of a computer. A nurse or a rehabilitator installs the EEG headset and places gel in the electrodes (x32). Connecting the amplifier and interface. Checking the correct positioning and contact of the electrodes (impedance).~* Calibration phase at rest.~* Working phase: the sessions last 24 minutes. The patient will be asked to concentrate on the affected arm, and to imagine a movement of this arm, to feel the sensations, without any real movement of the arm.~  * In the Neurofeedback group, the patient will receive visual feedback of a virtual hand moving on a computer screen in front of him/her, depending on his/her brain activations. He will also receive haptic feedback (vibrations) in the flexor muscles of his wrist.
Study NCT05884762 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: SHAM electroencephalographic neurofeedback
Description: The patient is installed in a quiet, isolated room in the Physical Medicine and Rehabilitation Department. The patient sits comfortably in front of a computer. A nurse or a rehabilitator installs the EEG headset and places gel in the electrodes (x32). Connecting the amplifier and interface. Checking the correct positioning and contact of the electrodes (impedance).~* Calibration phase at rest.~* Working phase: the sessions last 24 minutes. The patient will be asked to concentrate on the affected arm, and to imagine a movement of this arm, to feel the sensations, without any real movement of the arm.~  * In the SHAM group, the visual feedback and haptic feedback are randomly generated
Study NCT05184907 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote Motivational Enhancement (RME) Intervention Arm
Description: Participants will discuss the results of their CAT-MH, BAM, and PSS with a coach trained in motivational interviewing within 14 days of study randomization. Based on these results, the coach will help to identify behavior change goals, resolve ambivalence, amplify activation, explore their options, and empower the participant toward taking action to obtain appropriate support services tailored to their individual issues and concerns. The number of RME sessions will range from 1-3, determined by the participant's level of activation and desire to engage in additional sessions, as well as the number of challenges identified in their initial session or determined by their CAT-MH results. Participants will be sent a link at the end of week 1 with the aim to complete an action plan questionnaire, in which they will be asked to describe up to 3 action plan goals (in mental health, social services, and stress reduction/mental wellness categories).
Study NCT05184907 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Information Only
Description: Participants randomized to the information-only arm will have their CAT-MH, BAM, and PSS screening report results sent to their primary B/N prescriber and will encouraged to set up an appointment with their prescriber within 14 days to discuss the results. Participants will be sent a link at the end of week 1 with the aim to complete an action plan questionnaire, in which they will be asked to describe up to 3 action plan goals (in mental health, social services, and stress reduction/mental wellness categories).
Study NCT05011396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PH94B Nasal Spray
Description: Nasal spray delivered 20 minutes before the public speaking stressor
Study NCT05011396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Nasal Spray
Description: Nasal spray delivered 20 minutes before the public speaking stressor
Study NCT06368726 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS or Transcranial Direct Current Stimulation
Description: We use weak currents applied over the child's scalp over 30 minutes twice a week during 100 days
Study NCT06368726 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Risperidone
Description: Risperidone Risperidone according to child's weighs
Study NCT05726877 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ventilation strategy
Description: Titrating positive end-expiratory pressure
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma
Description: 3 injections of 10 cc of autologous Platelet Rich Plasma (PRP), weeks 1, 5 and 9
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shock waves therapy
Description: 6 sessions of focal shock waves, 1 per week
Study NCT04739020 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Resp-Aer-Meter
Description: Measurement of respiratory aerosols (particle size and concentration) through breathing into the Resp-Aer-Meter for 3-6 Minutes and comparison between groups.
Study NCT05207228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT4CBT
Description: Cognitive behavioral treatment through the web CBT4CBT
Study NCT04364204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care and BEMPU bracelet
Description: Kangaroo mother care involves early, continuous and prolonged skin-to-skin contact between a mother and her newborn, frequent and exclusive breastfeeding and early discharge from hospital. The BEMPU bracelet, also known as the BEMPU Tempwatch, is a silicone band with a thermistor metal cup that emits an audio alarm and flashes an orange light when the body temperature drops below 36.5⁰C, signaling hypothermia and prompting caregiver to provide thermal care.
Study NCT04364204 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kangaroo Mother Care
Description: Kangaroo mother care involves early, continuous and prolonged skin-to-skin contact between a mother and her newborn, frequent and exclusive breastfeeding and early discharge from hospital. This is the current standard of care for low birthweight/preterm infants.
Study NCT04739020 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Spirometry
Description: Comparison of peak expiratory flow (PEF) and forced expiratory volume in one second (FEV1) between groups.
Study NCT04739020 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Qualitative and quantitative virus PCR of respiratory secretions in patients with high aerosol concentrations
Description: Comparison between result of aerosol measurement and quantitative and qualitative virus PCR of respiratory secretions that are caught in a filter in which the patient breathes for 10 minutes. Test will be conducted on patients with high aerosol concentrations (>5000/L).
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Shock waves therapy
Description: 6 sessions of focal shock waves, 1 per week
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo PRP
Description: 3 injections of 10 cc of saline solution, weeks 1, 5 and 9
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo PRP
Description: 3 injections of 10 cc of saline solution, weeks 1, 5 and 9
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sham shock waves therapy
Description: 6 sessions of sham shock waves, 1 per week
Study NCT06433596 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham shock waves therapy
Description: 6 sessions of sham shock waves, 1 per week
Study NCT04446390 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Himalaya complete care toothpaste
Description: Herbal toothpaste as a part of a caries preventive regimen
Study NCT04446390 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: colgate cavity protection
Description: fluoride toothpaste as a part of a caries preventive regimen
Study NCT05731050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NM8074
Description: NM8074 will be administered as an intravenous infusion. All enrolled subjects will receive a dose of 15 mg/kg NM8074 once every two weeks for a total of 6 doses from Day1 to Day 84.~For Soliris-treated PNH subjects, admission and dosing of NM8074 on Day 1 should be scheduled to coincide with the next scheduled dose of Soliris (i.e., 14 ± 2 days after the last Soliris dose). Soliris should NOT be administered on Day 1 or at any time thereafter during course of the study.~Subjects in the treatment groups will receive a dose of 15 mg/kg of NM8074 on Day 1, which will be administered during the study visit by the site staff. During the remainder of the treatment period, subjects will be given another 15 mg/kg dose every two weeks at approximately the same time. On days of scheduled study visits at the Investigation Site, the dose must be administered after blood work is completed.
Study NCT04757428 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endocrown
Description: Endocrown
Study NCT04415424 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 4CMenB vaccine
Description: A four-component meningococcal B vaccine
Study NCT04415424 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.5 ml of 150 mmol sodium chloride (0.9% saline solution)
Study NCT04959123 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pharmacokinetic analysis
Description: Non-compartmental descriptive pharmacokinetic analysis (i.e. without the need for mathematical modelling), with determination of the pharmacokinetic parameters of interest either directly from the experimental points (Cmax, Tmax), or from simple mathematical equations (calculation of the area under the curve (AUC) by the trapezoidal method, calculation of the terminal slope of elimination)